Related Experiment Videos
Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction
Insights
Intravenous labetalol, an alpha- and beta-blocker, effectively lowered blood pressure in male patients post-myocardial infarction. Its vasodilating effects counteracted cardiac depression, with heightened sensitivity in hypertensive individuals.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction (AMI) can lead to significant hemodynamic changes.
- Understanding the effects of antihypertensive medications in the post-AMI period is crucial.
Purpose of the Study:
- To evaluate the hemodynamic effects of combined alpha- and beta-adrenoceptor blockade using intravenous labetalol.
- To assess the dose-response relationship and patient group variations in response to labetalol.
Main Methods:
- Twenty-one male patients with AMI (4-17 hours post-event, no heart failure) were studied.
- Patients were categorized by baseline systemic arterial pressure: high, normal, or low.
- Intravenous labetalol infusion was administered, with hemodynamic parameters (arterial pressure, cardiac output, filling pressures) monitored.
Main Results:
- Labetalol caused dose-related reductions in systolic and diastolic arterial pressure in all patients.
- The rate of blood pressure reduction correlated with initial systolic pressure.
- Cardiac output decreased initially but remained stable with continued infusion; left heart filling pressure was unchanged.
Conclusions:
- Labetalol's vasodilating action appears to balance its beta-blocker-induced cardiac depression.
- Hypertensive patients exhibited increased sensitivity to labetalol, potentially due to alpha-adrenoceptor-mediated vasoconstriction.
Abstract:
The haemodynamic consequences of combined alpha- and beta-adrenoceptor blockade with intravenous labetalol were evaluated in 21 males with either high (n = 6), normal (n = 9) or low (n = 6) systemic arterial pressure, 4-17 hours after acute myocardial infarction without heart failure. Labetalol 190 +/- 18 mg (range 62-300 mg) infusion resulted in dose-related falls in systolic (P less than 0.01) and diastolic (P less than 0.05) arterial pressure in all patients. The rate of pressure reduction per mg of infused labetalol was directly proportional to the control systolic arterial pressure. Cardiac output (thermodilution) was reduced (P less than 0.05) with low dose labetalol (39 +/- 5 mg) without change on continued infusion. Left heart filling pressure (pulmonary artery occluded pressure) was unchanged throughout infusion in all patients. In conclusion, the vasodilating properties of labetalol appeared to offset the beta-blocker induced depression of cardiac function. The increased sensitivity to the effects of labetalol in those patients with hypertension may be related to excessive alpha-adrenoceptor mediated vasoconstriction in this patient group.